eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
2/2019
vol. 15
 
Share:
Share:
more
 
 
abstract:
Clinical research

Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis

Dariusz Kotlęga, Monika Gołąb-Janowska, Agnieszka Meller, Anna Bajer-Czajkowska, Agnieszka Zembroń-Łacny, Przemysław Nowacki, Maciej Banach

Arch Med Sci 2019; 15, 2: 385–392
Online publish date: 2019/03/04
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Statins are widely used in stroke patients. The AHA/ASA guidelines recommend aggressive statin therapy in atherosclerotic stroke patients. Their beneficial effects are due to both their hypolipemic and pleiotropic properties. The aim of this study was to establish potential benefits from statin use in ischemic stroke patients with the diagnosis of atrial fibrillation (AF).

Material and methods
Ischemic stroke patients with AF were enrolled in the study. Group I, the statin group (n = 181), consisted of patients who had been treated with statins before stroke. Group II, the non-statin group (n = 153), consisted of patients who had not received such treatment in the last year. In-hospital mortality and neurological deficit on admission and at discharge were analyzed using the National Institutes of Health Stroke Scale (NIHSS) score.

Results
Patients from the non-statin group had greater initial and discharge NIHSS scores (10 vs. 11.9, probability value p < 0.05; 7.6 vs. 9.5, p < 0.05 respectively). The improvement in NIHSS score was greater in the statin group (73.5% vs. 59.5%, p < 0.01). In-hospital mortality was more frequent in the non-statin group (9.9% vs. 18.3%, p < 0.05).

Conclusions
Despite the predominant use of statins in atherothrombotic stroke patients, we demonstrated the beneficial effects of statins in cardioembolic stroke patients. Detailed cardiovascular screening for statin therapy should be carried out in all AF patients with regard to primary and secondary stroke prevention.

keywords:

stroke, outcome, atrial fibrillation, anticoagulant prophylaxis, statin, embolism

references:
Sienkiewicz-Jarosz H, Głuszkiewicz M, Pniewski J, et al. Zapadalność i wskaźnik śmiertelności dla pierwszego w życiu udaru mózgu – porównanie dwóch warszawskich badań populacyjnych. Neurol Neurochir Pol 2011; 45: 207-12.
Kotlęga D, Ciećwież S, Turowska-Kowalska J, Nowacki P. Pathogenetic justification of statin use in ischaemic stroke prevention according to inflammatory theory in development of atherosclerosis. Neurol Neurochir Pol 2012; 46:176-83.
Gołąb-Janowska M, Meller A, Kotlęga D, Bajer-Czajkowska A, Nowacki P. Atrial fibrillation and stroke – coexistence and attitude to preventive therapy on the basis of Szczecin and Szczecin region patients. Neurol Neurochir Pol 2014; 48: 410-5.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-8.
Saposnik G, Gladstone D, Raptis R, Zhou L, Hart RD; the Investigators of the Registry of the Canadian Stroke Network (RCSN) and the Stroke Outcomes Research Canada (SORCan) Working Group. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke 2013; 44: 99-104.
van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002; 288: 2441-8.
Wang W, Zhang B. Statins for the prevention of stroke: a meta-analysis of randomized controlled trials. PLoS One 2014; 9: e92388.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
Kernan WN, Ovbiagele B, Black HR, et al.; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160-236.
Soran H, Adam S, Mohammad JB, et al. Hypercholesterolaemia – practical information for non-specialists. Arch Med Sci 2018; 14: 1-21.
Zanchetti A, Liu L, Mancia G, et al. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens 2014; 32: 1888-97.
Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J. Time for new indications for statins? Med Sci Monit 2009; 15: MS1-5.
Cheng HG, Patel BS, Martin SS, et al. Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community-based prevention clinic. Arch Med Sci 2016; 12: 728-35.
Collins R, Armitage J, Parish S, Sleight P, Peto R. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004; 363: 757-67.
Amarenco P, Bogousslavsky J, Callahan A III, et al.; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-59.
Furie KL. High-dose statins should only be used in atherosclerotic strokes. Stroke 2012; 43: 1994-5.
Kotlęga D, Gołąb-Janowska M, Masztalewicz M, Cieć­wież S, Nowacki P. Potential role of statins in the intracerebral hemorrhage and subarachnoid hemorrhage. Neurol Neurochir Pol 2015; 49: 322-8.
Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-4.
Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083-92.
Lee MJ, Bang OY, Kim SJ, et al. Role of statin in atrial fibrillation-related stroke: an angiographic study for collateral flow. Cerebrovasc Dis 2014; 37: 77-84.
Watanabe E, Yamashita T, Suzuki S, et al.; Investigators TJ. Statin treatment for patients with paroxysmal atrial fibrillation. Int Heart J 2011; 52: 103-6.
Ntaios G, Papavasileiou V, Makaritsis K, et al. Statin treatment is associated with improved prognosis in patients with AF-related stroke. Int J Cardiol 2014; 177: 129-33.
Ní Chróinín D, Asplund K, Åsberg S, et al. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke 2013; 44: 448-56.
Snarska KK, Bachórzewska-Gajewska H, Kapica-Topczewska K, et al. Hyperglycemia and diabetes have different impacts on outcome of ischemic and hemorrhagic stroke. Arch Med Sci 2017; 13: 100-8.
Adams Jr HP, del Zoppo G, Alberts MJ, et al.; American Heart Association/American Stroke Association Stroke Council; American Heart Association/American Stroke Association Clinical Cardiology Council; American Heart Association/American Stroke Association Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease Working Group; Quality of Care Outcomes in Research Interdisciplinary Working Group. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists, Circulation 2007; 115: e478-534.
Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54: 541-53.
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
Stead LG, Vaidyanathan L, Kumar G, et al. Statins in ischemic stroke: just low-density lipoprotein lowering or more? J Stroke Cerebrovasc Dis 2009; 18: 124-7.
Ko D, Thigpen JL, Otis JA, et al. Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation. Int J Cardiol 2017; 227: 808-12.
Choi JY, Seo WK, Kang SH, et al. Statins improve survival in patients with cardioembolic stroke. Stroke 2014; 45: 1849-52.
Ntaios G, Papavasileiou V, Makaritsis K, et al. Statin treatment is associated with improved prognosis in patients with AF-related stroke. Int J Cardiol 2014; 177: 129-33.
Wu YL, Saver JL, Chen PC, et al. Effect of statin use on clinical outcomes in ischemic stroke patients with atrial fibrillation. Medicine (Baltimore) 2017; 96: e5918.
Zembala M, Filipiak K, Kowalski O, et al. Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus rhythm in long-term observation. Arch Med Sci 2017; 13: 109-17.
Banach M, Jankowski P, Jóźwiak J, et al. PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016. Arch Med Sci 2017; 13: 1-45.
Xia SJ, Du X, Li C, et al. Uptake of evidence-based statin therapy among atrial fibrillation patients in China: a report from the CAFR (Chinese Atrial Fibrillation Registry) Study. Int J Cardiol 2016; 220: 284-9.
Bogiatzi C, Hackam DG, McLeod AI, Spence JD. Secular trends in ischemic stroke subtypes and stroke risk factors. Stroke 2014; 45: 3208-13.
Tsivgoulis G, Kadlecová P, Kobayashi A, et al. Safety of statin pretreatment in intravenous thrombolysis for acute ischemic stroke. Stroke 2015; 46: 2681-4.
FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe